Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Trending weight loss drugs such as Ozempic and Wegovy may be highly effective at tackling obesity, but are they also carrying ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

I don’t eat before noon – but I worry it’s a bad idea - IN FOCUS: Depending on which research you read, breakfast is either ...

Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.